Journal
Multiple sclerosis (Houndmills, Basingstoke, England)
Publication Date
9-1-2022
Volume
28
Issue
10
First Page
1562
Last Page
1575
Document Type
Open Access Publication
DOI
10.1177/13524585221078825
Rights and Permissions
Gärtner J, Hauser SL, Bar-Or A, Montalban X, Cohen JA, Cross AH, Deiva K, Ganjgahi H, Häring DA, Li B, Pingili R, Ramanathan K, Su W, Willi R, Kieseier B, Kappos L. Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II. Mult Scler. 2022 Sep;28(10):1562-1575. doi: 10.1177/13524585221078825. © The Author(s), 2022. CC-BY-NC
Recommended Citation
Gärtner, Jutta; Hauser, Stephen L; Bar-Or, Amit; Montalban, Xavier; Cohen, Jeffrey A; Cross, Anne H; Deiva, Kumaran; Ganjgahi, Habib; Häring, Dieter A; Li, Bingbing; Pingili, Ratnakar; Ramanathan, Krishnan; Su, Wendy; Willi, Roman; Kieseier, Bernd; and Kappos, Ludwig, "Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II." Multiple sclerosis (Houndmills, Basingstoke, England). 28, 10. 1562 - 1575. (2022).
https://digitalcommons.wustl.edu/oa_4/21